Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-12-16
pubmed:abstractText
We previously reported two modes of development of acquired TRAIL resistance: early phase and late phase [1]. In these studies, we observed that greater Akt activity and the expression of Bcl-xL were related mainly to the late phase of acquired TRAIL resistance. Recently we became aware of a possible mechanism of early phase TRAIL resistance development through internalization and degradation of TRAIL receptors (DR4 and DR5). Our current studies demonstrate that TRAIL receptors rapidly diminish at the membrane as well as the cytoplasm within 4h after TRAIL exposure, but recover completely after one or two days. Our studies also reveal that Cbl, a ubiquitously expressed cytoplasmic adaptor protein, is responsible for the rapid degradation of TRAIL receptors; Cbl binds to them and induces monoubiquitination of these receptors concurrent with their degeneration soon after TRAIL exposure, creating the early phase of acquired TRAIL resistance.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-10393178, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-10754286, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-11223029, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-11283727, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-11607840, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-11724969, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-11894095, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-11997497, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12189384, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12429913, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12651740, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12655296, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12717448, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12719435, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12754251, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-12787570, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-14570567, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-14607090, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-15006537, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-15117950, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-15120327, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-15210722, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-15598658, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-15737992, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-16482222, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-16498403, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-17024246, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-17110373, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-17327223, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-8649859, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-8920860, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9082980, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9259313, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9311998, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9430226, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9525940, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9603945, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9851973, http://linkedlifedata.com/resource/pubmed/commentcorrection/19932172-9890970
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1873-3913
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
553-63
pubmed:dateRevised
2011-7-25
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.
pubmed:affiliation
Institute for Cancer Research, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
pubmed:publicationType
Journal Article
More...